EFFECTS OF INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN AIDS-KAPOSIS SARCOMA

被引:24
作者
LOUIE, S
CAI, J
LAW, R
LIN, G
LUNARDIISKANDAR, Y
JUNG, B
MASOOD, R
GILL, P
机构
[1] UNIV SO CALIF,KENNETH NORRIS JR COMPREHENS CANC CTR,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH PHARM,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90033
[4] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1995年 / 8卷 / 05期
关键词
KAPOSIS SARCOMA; INTERLEUKIN-1; RECEPTOR;
D O I
10.1097/00042560-199504120-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Kaposi's sarcoma (KS) is the most common tumor seen in patients with HIV-1 infection. HIV-1 may induce KS directly through viral protein(s) or indirectly through regulation of cytokines such as IL-1 and IL-6. We have shown that AIDS-KS spindle cells express IL-1 beta and that IL-1ra inhibits KS-spindle cell growth. IL-1ra had little effect on human umbilical vein endothelial cells (HUVEC), human aortic smooth muscle cells (HASM), and human foreskin fibroblast (NN41). These findings support an autocrine activity for IL-1. Furthermore, exogenous IL-1 can enhance AIDS-KS cell growth, and this effect is completely blocked by IL-1ra. As expected, IL-1ra also blocks IL-1 mediated upregulation of IL-6 and bFGF, both of which are autocrine growth factors for KS, IL-1ra is thus a potential candidate for the treatment of AIDS-associated KS.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 18 条
[1]  
AREND WP, 1989, J IMMUNOL, V143, P1851
[2]   EFFECTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN ON THE EXPRESSION OF INFLAMMATORY CYTOKINES [J].
BUONAGURO, L ;
BARILLARI, G ;
CHANG, HK ;
BOHAN, CA ;
KAO, V ;
MORGAN, R ;
GALLO, RC ;
ENSOLI, B .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7159-7167
[3]  
CORBEIL J, 1991, J IMMUNOL, V146, P2972
[4]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[5]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346
[6]   CYTOKINES AND GROWTH-FACTORS IN THE PATHOGENESIS OF AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
ENSOLI, B ;
BARILLARI, G ;
GALLO, RC .
IMMUNOLOGICAL REVIEWS, 1992, 127 :147-155
[7]   DISSEMINATED KAPOSIS SARCOMA SYNDROME IN YOUNG HOMOSEXUAL MEN [J].
FRIEDMANKIEN, AE .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 5 (04) :468-471
[8]   INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR [J].
HANNUM, CH ;
WILCOX, CJ ;
AREND, WP ;
JOSLIN, FG ;
DRIPPS, DJ ;
HEIMDAL, PL ;
ARMES, LG ;
SOMMER, A ;
EISENBERG, SP ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :336-340
[9]  
LONGO N, 1993, J ACQ IMMUN DEF SYND, V6, P1017
[10]   POTENTIATION OF CYTOTOXICITY OF KAPOSIS-SARCOMA RELATED TO IMMUNODEFICIENCY SYNDROME (AIDS) BY LIPOSOME-ENCAPSULATED DOXORUBICIN [J].
MASOOD, R ;
HUSAIN, SR ;
RAHMAN, A ;
GILL, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (08) :741-746